2008
DOI: 10.1016/j.metabol.2007.10.021
|View full text |Cite
|
Sign up to set email alerts
|

RGS2 C1114G polymorphism and body weight gain in hypertensive patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 34 publications
(52 reference statements)
0
12
0
Order By: Relevance
“…Some factors may potentially interact with bariatric surgery and result in highly variable outcomes in terms of weight loss and glycemic control afterwards. Much obesity research suggests that genes are strongly implicated in obesity and weight gain [17,37,38]. Evidence also shows that genes not only affect weight gain but also interact with other medical factors to influence weight loss and glycemic control [39][40][41][42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…Some factors may potentially interact with bariatric surgery and result in highly variable outcomes in terms of weight loss and glycemic control afterwards. Much obesity research suggests that genes are strongly implicated in obesity and weight gain [17,37,38]. Evidence also shows that genes not only affect weight gain but also interact with other medical factors to influence weight loss and glycemic control [39][40][41][42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…Human and mouse studies have also implicated RGS2, 4 and 5, in the regulation of body weight and obesity [48], [49], [50], [51]. However these RGS proteins and RGS9 likely regulate body weight through different mechanisms: RGS2, 4 and 5 are members of a different R4 subfamily of RGS proteins, have a different molecular architecture and strikingly different cellular and tissue expression patterns compared to RGS9 [18], [37], [52].…”
Section: Discussionmentioning
confidence: 99%
“…By contrast, our work has shown that the R44H variant of RGS2, although not compromising stability, did disrupt the amphipathic α-helix that is crucial for proper plasma-membrane targeting and function [38]. Notably, another mutation at the Arg 44 position, R44G, has also been shown to be associated with hypertension and higher than normal BMI (body mass index) [39], perhaps suggesting a link between RGS2 and obesity and the metabolic syndrome. In addition to those changes identified in the coding regions, the promoter region, introns and untranslated regions of RGS2 also contain several SNPs and I/D (insertion/deletion) polymorphisms, of which one has been shown to result in enhanced calcium mobilization in fibroblasts in their response to AngII [40], and one that has been linked to an increase in risk of the metabolic syndrome in white Caucasian Europeans [34].…”
Section: Clinical Hypertension: Implications For Its Association Withmentioning
confidence: 59%